These results suggest that ANP32A is commonly increased in oral squamous cell carcinoma and ANP32A protein could act as a potential biomarker for prognosis assessment of oral cancer patients with lymph node metastasis. The gene discussed is ANP32A; the disease is metastatic malignant neoplasm in the lymph nodes.